Tag: Therapeutics
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
Business Combination of Amicus Gene Therapy Business with ARYA IV to Result in the Launch of Caritas Therapeutics, a New Independent, Publicly Traded Company with Expected ~$400M in Initial Funding Will Transform Amicus into a Premier Global Commercialization and Late Stage Product Development Biotechnology Company in Rare Diseases Transaction Advances Amicus Path to Profitability – Expected as
Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics
Collaboration Will Continue to Work Towards Identifying Biomarkers for Protective Immunity Against SARS-CoV-2 Immune Correlates of Protection May Support Development of New and Specialized Vaccines to Protect Against COVID-19 Potential for Developing Antibody-Based COVID-19 Therapeutics as a Result of the Collaboration CHATHAM, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP)